K Number
K050365
Manufacturer
Date Cleared
2005-12-27

(316 days)

Product Code
Regulation Number
864.7290
Panel
HE
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Biophen Protein C 5 & 2.5 kit is a Chromogenic assay for measuring the Protein C Activity in human citrated plasma using a manual or an automated method. Biophen Protein C 5 & 2.5 Kit is a Chromogenic assay for measuring the Protein C Activity in human citrated plasma using a manual or an automated method.

Device Description

Biophen Protein C is a chromogenic assay consisting of chromogenic substrate and Protein C activator.

AI/ML Overview

This document describes a 510(k) submission for the "Biophen Protein C 5 & 2.5" device, a chromogenic assay for the quantitative determination of Protein C activity in human plasma. The submission focuses on demonstrating substantial equivalence to a predicate device, the "Coamatic Protein C".

1. A table of acceptance criteria and the reported device performance

The document does not explicitly state "acceptance criteria" for the Biophen Protein C device. Instead, it presents performance data for "Intra-Assay CV%" and "Inter-Assay CV%", which are common metrics for assay precision. The implication is that these performance characteristics are considered acceptable due to their similarity to the predicate device, which is already legally marketed.

MetricAcceptance Criteria (Implied by Predicate Performance)Reported Device Performance (Biophen Protein C 5 & 2.5)
Intra-Assay CV%Not explicitly stated; likely

§ 864.7290 Factor deficiency test.

(a)
Identification. A factor deficiency test is a device used to diagnose specific coagulation defects, to monitor certain types of therapy, to detect coagulation inhibitors, and to detect a carrier state (a person carrying both a recessive gene for a coagulation factor deficiency such as hemophilia and the corresponding normal gene).(b)
Classification. Class II (performance standards).